-
Serve as a senior clinical leader representing Caris’ malignant hematology expertise with credibility, business maturity, and strong executive communication in external and internal engagements.
-
Cultivate and lead strategic relationships with key opinion leaders (KOLs), clinical collaborators, POA institutions, and industry partners to elevate the Caris brand and drive scientific engagement.
-
Provide strategic direction and clinical guidance in partnership with Research & Development, Medical Affairs, Commercial, and Business Development teams to support innovation, market expansion, and product refinement.
-
Act as a trusted advisor and internal leader, supporting cross-functional teams by translating scientific insights into business-aligned actions and product evolution.
-
Collaborate closely with field sales (Key Account Directors and Executive Sales Management) and the Business Development team to advance Caris’ visibility, strengthen customer trust, and identify new partnership opportunities.
-
Lead high-impact scientific communications, including public speaking engagements at national/international forums, advisory boards, investigator meetings, and Caris-sponsored events.
-
Drive scientific and educational strategies: oversee content development for publications, slide libraries, clinical education materials, and professional/continuing education programs.
-
Mentor and provide training to field-based medical professionals, including Medical Science Liaisons, supporting their development and alignment with business goals.
-
Represent Medical Affairs on the Caris Evidence Team, contributing thought leadership to the development of evidence frameworks, clinical association rules, and product positioning.
-
Review marketing, promotional, and educational materials to ensure alignment with clinical data, regulatory guidelines, and Caris’ strategic messaging.
-
Provide a critical communication bridge between the marketplace and internal R&D/Product Development teams, ensuring the voice of the clinician and evolving clinical trends inform product strategy.
-
MD or DO, board-certified in Hematology and Medical Oncology.
-
Minimum of 3 years recent clinical practice focused on malignant hematologic diseases, including acute leukemia, myelodysplastic syndromes, myeloproliferative disorders, and multiple myeloma.
-
Demonstrated leadership in clinical or industry roles, with a strong ability to lead cross-functional teams and influence senior-level stakeholders.
-
Significant experience with public speaking and scientific presentation, with the ability to communicate complex ideas effectively to both scientific and non-scientific audiences.
-
Proven track record of integrating clinical knowledge into product strategy, including experience with product lifecycle planning, clinical value positioning, and market readiness.
Caris Life Sciences was founded in 2008 with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. With transformative technologies informed by massive amounts of big data, we are revolutionizing healthcare to provide physicians and patients with the highest quality information about their disease – from detecting it early and determining how best to treat it, to developing the next wave of novel therapies.